The intent of this proposal is to expand the content of NSF/ANSI 173 with respect to its references to known toxic constituents by establishing a Maximum Allowable Level (MAL) for pyrrolizidine alkaloids (PAs) in dietary supplements and ingredients.
05189: Approval of 173i83r1 - Pyrrolizidine Alkaloids
Document (Archive)
2018-08-17
DS-2018-9 Pyrrolizidine Alkaloids- 173i83.pdf
Document
2018-07-26
About UsParticipateTerms of UsePrivacy Policy